Lyons Gary A - May 21, 2025 Form 4 Insider Report for NEUROCRINE BIOSCIENCES INC (NBIX)

Role
Director
Signature
/s/ Darin Lippoldt, Attorney-in-Fact
Stock symbol
NBIX
Transactions as of
May 21, 2025
Transactions value $
$0
Form type
4
Date filed
5/22/2025, 05:18 PM
Previous filing
May 16, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
LYONS GARY A Director 6027 EDGEWOOD BEND COURT, SAN DIEGO /s/ Darin Lippoldt, Attorney-in-Fact 2025-05-22 0001123343

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NBIX Common Stock Options Exercise $0 +1.44K +1.21% $0.00 120K May 22, 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NBIX Restricted Stock Unit Award $0 +1.66K $0.00 1.66K May 21, 2025 Common Stock 1.66K $0.00 Direct F2, F3
transaction NBIX Non-Qualified Stock Option Award $0 +3.31K $0.00 3.31K May 21, 2025 Common Stock 3.31K $120.56 Direct F4
transaction NBIX Restricted Stock Unit Options Exercise $0 -1.44K -100% $0.00 0 May 22, 2025 Common Stock 1.44K $0.00 Direct F2, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 114,499 of the reported shares are held by the Gary A. Lyons Revocable Living Trust U/A 6/8/12, of which the Reporting Person has voting and investment power
F2 Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's common stock upon vesting.
F3 The RSUs will vest in full on May 21, 2026.
F4 Option vests in 12 monthly installments beginning June 21, 2025.
F5 This RSU award was granted to the Reporting Person on May 22, 2024 and is fully vested.